The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines

Commentary notes approvals of first COVID-19 vaccines in EU are a key milestone in response to COVID-19, which not only offer hope to control the pandemic but also provide proof of concept for a new approach to vaccine development in response to future emerging health threats.

Source:

The Lancet